117 related articles for article (PubMed ID: 7639615)
1. Adenosine receptors: protein and gene structure.
Olah ME; Ren H; Stiles GL
Arch Int Pharmacodyn Ther; 1995; 329(1):135-50. PubMed ID: 7639615
[TBL] [Abstract][Full Text] [Related]
2. Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.
Olah ME; Jacobson KA; Stiles GL
J Biol Chem; 1994 Oct; 269(40):24692-8. PubMed ID: 7929142
[TBL] [Abstract][Full Text] [Related]
3. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
Rivkees SA; Lasbury ME; Barbhaiya H
J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptor subtypes: characterization and therapeutic regulation.
Olah ME; Stiles GL
Annu Rev Pharmacol Toxicol; 1995; 35():581-606. PubMed ID: 7598508
[TBL] [Abstract][Full Text] [Related]
5. Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists.
Olah ME; Jacobson KA; Stiles GL
J Biol Chem; 1994 Jul; 269(27):18016-20. PubMed ID: 8027060
[TBL] [Abstract][Full Text] [Related]
6. Separate promoters in the human A1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance.
Ren H; Stiles GL
Mol Pharmacol; 1995 Dec; 48(6):975-80. PubMed ID: 8848013
[TBL] [Abstract][Full Text] [Related]
7. The role of receptor structure in determining adenosine receptor activity.
Olah ME; Stiles GL
Pharmacol Ther; 2000 Feb; 85(2):55-75. PubMed ID: 10722120
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. Analysis of a chimeric A1-A3 adenosine receptor.
Palmer TM; Benovic JL; Stiles GL
J Biol Chem; 1996 Jun; 271(25):15272-8. PubMed ID: 8663009
[TBL] [Abstract][Full Text] [Related]
9. Identification of A2a adenosine receptor domains involved in selective coupling to Gs. Analysis of chimeric A1/A2a adenosine receptors.
Olah ME
J Biol Chem; 1997 Jan; 272(1):337-44. PubMed ID: 8995267
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing.
Ren H; Stiles GL
J Biol Chem; 1994 Jan; 269(4):3104-10. PubMed ID: 8300646
[TBL] [Abstract][Full Text] [Related]
11. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
Piersen CE; True CD; Wells JN
Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1995 Jun; 47(6):1172-9. PubMed ID: 7603457
[TBL] [Abstract][Full Text] [Related]
13. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
Longabaugh JP; Didsbury J; Spiegel A; Stiles GL
Mol Pharmacol; 1989 Nov; 36(5):681-8. PubMed ID: 2511426
[TBL] [Abstract][Full Text] [Related]
14. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
Ivanov AA; Palyulin VA; Zefirov NS
J Mol Graph Model; 2007 Jan; 25(5):740-54. PubMed ID: 17095272
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of recombinant bovine A1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition.
Figler RA; Graber SG; Lindorfer MA; Yasuda H; Linden J; Garrison JC
Mol Pharmacol; 1996 Dec; 50(6):1587-95. PubMed ID: 8967981
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
17. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
18. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J
Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976
[TBL] [Abstract][Full Text] [Related]
19. Cyclopentyladenosine-induced homologous down-regulation of A1 adenosine receptors (A1AR) in intact neurons is accompanied by receptor sequestration but not a reduction in A1AR mRNA expression or G protein alpha-subunit content.
Hettinger BD; Leid M; Murray TF
J Neurochem; 1998 Jul; 71(1):221-30. PubMed ID: 9648869
[TBL] [Abstract][Full Text] [Related]
20. Posttranscriptional mRNA processing as a mechanism for regulation of human A1 adenosine receptor expression.
Ren H; Stiles GL
Proc Natl Acad Sci U S A; 1994 May; 91(11):4864-66. PubMed ID: 8197148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
